Invention Grant
US09434783B2 Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
有权
缩短的CD95-Fc变体融合蛋白，其核酸和宿主细胞
- Patent Title: Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
- Patent Title (中): 缩短的CD95-Fc变体融合蛋白，其核酸和宿主细胞
-
Application No.: US14415871Application Date: 2013-07-18
-
Publication No.: US09434783B2Publication Date: 2016-09-06
- Inventor: Oliver Hill , Christian Gieffers , Meinolf Thiemann
- Applicant: Apogenix GmbH
- Applicant Address: DE Heidelberg
- Assignee: APOGENIX AG
- Current Assignee: APOGENIX AG
- Current Assignee Address: DE Heidelberg
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Priority: EP12176978 20120718; EP12176980 20120718
- International Application: PCT/EP2013/065248 WO 20130718
- International Announcement: WO2014/013037 WO 20140123
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C07K14/705 ; C07K7/08 ; C07K16/00 ; C07K14/525
Abstract:
The present invention relates to an isolated fusion protein comprising an extracellular CD95 domain or a functional fragment thereof and an Fc domain or functional fragment thereof, formulations providing such fusion protein in a stable form as well as a method for producing such a fusion protein.
Public/Granted literature
- US20150166633A1 SHORTENED CD95-FC VARIANTS Public/Granted day:2015-06-18
Information query
